Arcagy Research

ARCAGY (Association de Recherche sur les CAncers Gynécologiques) is a prominent French academic research organization (ARO) focused on clinical research in gynecological oncology. It provides the legal and administrative framework for the GINECO group, a national network of clinicians and researchers dedicated to improving treatments for ovarian, endometrial, and cervical cancers. ARCAGY is a founding member of the European Network for Gynaecological Oncological Trial groups (ENGOT) and actively participates in the Gynecologic Cancer InterGroup (GCIG). The organization has led or co-led numerous landmark Phase 2 and Phase 3 clinical trials that have significantly influenced international treatment guidelines. By collaborating with global pharmaceutical partners, ARCAGY facilitates the evaluation of novel agents, including PARP inhibitors and immunotherapies, in the gynecologic cancer setting. Its work spans from early-phase translational research to large-scale international registration trials. ARCAGY also maintains a significant focus on patient quality of life and the development of educational resources for both medical professionals and patients.